Literature DB >> 8766853

Gene expression of syndecans and betaglycan in isolated rat liver cells.

O H Weiner1, M Zoremba, A M Gressner.   

Abstract

Membrane-bound heparan sulfate proteoglycans act as coreceptors for cytokines and are involved in cell-matrix or cell-cell adhesion. We have determined the gene expression of all four members of the syndecan-like integral membrane proteoglycans and of betaglycan, the transforming growth factor-beta type III receptor, in various types of isolated hepatic cells of the rat. Fat-storing cells express syndecan-1, -2, -3, -4, and betaglycan. During the transformation of fat-storing cells into myofibroblasts (the key process in the development of liver cirrhosis), the levels of mRNA for syndecan-1, -3, and -4 remain constant, whereas the amount of syndecan-2 mRNA increases and that for betaglycan decreases. Liver macrophages express syndecan-3 and -4, but only small amounts of syndecan-1. Freshly isolated hepatocytes express only syndecan-1, -2, and -4, but fail to express betaglycan. During cultivation, hepatocytes start to express betaglycan. Syndecan-3, -4, and betaglycan are transcribed into one mRNA population, whereas syndecan-1 and -2 are expressed in different-sized mRNA populations. The data show that the genes of all tested membrane heparan sulfate proteoglycans are expressed by hepatic cells, but that each cell type is characterized by its specific heparan sulfate proteoglycan mRNA profile.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766853     DOI: 10.1007/s004410050615

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  8 in total

1.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

2.  Autocrine-controlled formation and function of tissue-like aggregates by primary hepatocytes in micropatterned hydrogel arrays.

Authors:  Courtney M Williams; Geeta Mehta; Shelly R Peyton; Adam S Zeiger; Krystyn J Van Vliet; Linda G Griffith
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

3.  Photopatterning of hydrogel scaffolds coupled to filter materials using stereolithography for perfused 3D culture of hepatocytes.

Authors:  Jaclyn A Shepard Neiman; Ritu Raman; Vincent Chan; Mary G Rhoads; Micha Sam B Raredon; Jeremy J Velazquez; Rachel L Dyer; Rashid Bashir; Paula T Hammond; Linda G Griffith
Journal:  Biotechnol Bioeng       Date:  2015-02-23       Impact factor: 4.530

4.  Syndecan-1 - A new piece in B-cell puzzle.

Authors:  L Kopper; A Sebestyén; M Gallai; I Kovalszky
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

5.  Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver.

Authors:  Kinji Asahina; Hajime Sato; Chihiro Yamasaki; Miho Kataoka; Miho Shiokawa; Shigeru Katayama; Chise Tateno; Katsutoshi Yoshizato
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

6.  Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.

Authors:  Kristin I Stanford; Joseph R Bishop; Erin M Foley; Jon C Gonzales; Ingrid R Niesman; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

7.  Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.

Authors:  Xu Zhao; Jian Hao; Sinuan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-14       Impact factor: 2.629

8.  Differential expression of syndecans and glypicans in chronically inflamed synovium.

Authors:  A M Patterson; A Cartwright; G David; O Fitzgerald; B Bresnihan; B A Ashton; J Middleton
Journal:  Ann Rheum Dis       Date:  2007-06-01       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.